• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

How Common is Noonan Syndrome When the NT is Large but Chromosomes Appear Normal?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE: 

  • Noonan syndrome is an autosomal dominant disorder that occurs in approximately 1 in 1,000 to 2,500 people 
  • It is the most common single gene disorder seen with NT and a well-known finding in association with cystic hygroma   
  • Ali et al. (Prenatal Diagnosis, 2017) sought to determine the prevalence of Noonan syndrome in fetuses with increased nuchal translucency (NT) thickness in the first trimester of pregnancy 

METHODS: 

  • Retrospective cohort study 
  • Centers all with AIUM certified prenatal diagnostic units, and NTQR certified teams  
  • Inclusion criteria 
    • First trimester NT measurement ≥ 3 mm 
    • Normal karyotype by either a CVS or an amniocentesis  
    • Prenatal molecular genetic testing for Noonan syndrome available 
  • 2 labs reported results 
    • Lab 1: 9 Noonan syndrome genes plus Costello and CFC syndromes  
    • Lab 2: 7 Noonan syndrome genes plus Costello and CFC syndromes  
      • Two genes not screened were NRAS and RIT1, but only make up 5% of Noonan syndrome postnatally  
    • Costello and CFC (cardiofaciocutaneous) syndromes have overlapping features with Noonan syndrome
  • Positive report: Known pathogenic variants in any tested gene 
  • Negative report: Variants of uncertain clinical significance or no variants 

RESULTS: 

  • 804 fetuses had NT measurement of ≥ 3 mm 
    • Median NT was 3.6 mm 
  • 302 (37.6%) had karyotyping by CVS or amnio 
    • 200 (66.2%) had normal results 
  • No molecular testing in 161 fetuses with normal karyotype (mean NT thickness 4.3 mm)  
  • 39 fetuses with normal karyotype (median NT thickness of 4.0 mm) were screened for Noonan syndrome  
  • 4 fetuses (10.3%) had variants consistent with this Noonan syndrome 

CONCLUSION: 

  • Increased nuchal translucency (NT) is associated with a 10% risk of Noonan syndrome 
  • Confirms previously reported literature (see Croonen et al; European Journal of Human Genetics, 2013) 

Learn More – Primary Sources:  

Ali et al. Testing for Noonan syndrome after increased nuchal translucency 

Prenatal diagnostic testing of the Noonan syndrome genes in fetuses with abnormal ultrasound findings 

image_pdfFavoriteLoadingFavorite

< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Large NT but Normal Karyotype? Noonan Syndrome Basics
Practical obstetrics info for your women's healthcare practice
Nuchal Translucency – First Trimester Measurement

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site